{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:15:42Z","timestamp":1766733342407,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Chordoma is a rare malignant neoplasm derived from notochordal tissue that primarily affects the axial skeleton. Almost 40% of patients have non-cranial chordoma metastases. The most common metastatic sites are the lungs, bones, lymph nodes, and subcutaneous tissue. We present a 52-year female with a history of sacral chordoma presenting with abdominal fullness, early satiety, and a palpable abdominal mass. Abdominal magnetic resonance imaging (MRI) revealed an isolated, highly vascularized, and multilobed liver mass in the left lateral segment. The mass was surgically removed using a clean surgical margin. A histological examination and immunohistochemical staining were consistent with a metastatic chordoma. Two years later, follow-up imaging studies showed a 6.5 \u00d7 4.0 \u00d7 2.0 cm right liver lesion with multiple lungs, chest wall, pleural, and diaphragmatic lesions. Microscopic- and immunohistochemical staining revealed a recurrent metastatic chordoma. Herein, we present a unique case of metastatic recurrent chordoma in the liver with the involvement of other sites. To the best of our knowledge, no other case of recurrent liver metastasis has been reported.<\/jats:p>","DOI":"10.3390\/curroncol29070367","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:53:02Z","timestamp":1656622382000},"page":"4625-4631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recurrent Metastatic Chordoma to the Liver: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"29","author":[{"given":"Thomas E.","family":"Dickerson","sequence":"first","affiliation":[{"name":"Medical College of Georgia, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Pathology, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathvik","family":"Saineni","sequence":"additional","affiliation":[{"name":"Medical College of Georgia, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandresh","family":"Sultan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Bolan Medical College, Quetta 83700, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1972-5787","authenticated-orcid":false,"given":"Srikar","family":"Sama","sequence":"additional","affiliation":[{"name":"Medical College of Georgia, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intisar","family":"Ghleilib","sequence":"additional","affiliation":[{"name":"Department of Pathology, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil G.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam A.","family":"Elhelf","sequence":"additional","affiliation":[{"name":"Department of Radiology, Augusta University, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagla Abdel","family":"Karim","sequence":"additional","affiliation":[{"name":"Inova Schar Cancer Institute, University of Virginia, Fairfax, VA 22031, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Young, V.A., Curtis, K.M., Temple, H.T., Eismont, F.J., Delaney, T.F., and Hornicek, F.J. (2015). Characteristics and patterns of metastatic dis-ease from chordoma. Sarcoma, 2015.","DOI":"10.1155\/2015\/517657"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3171\/spi.2006.5.4.277","article-title":"Metastatic disease from spinal chordoma: A 10-year experience","volume":"5","author":"McPherson","year":"2006","journal-title":"J. Neurosurg. Spine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/S1470-2045(11)70337-0","article-title":"Chordoma: Current concepts, management, and future directions","volume":"13","author":"Walcott","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008947301735","article-title":"Chordoma: Incidence and survival patterns in the United States, 1973\u20131995","volume":"12","author":"McMaster","year":"2001","journal-title":"Cancer Causes Control"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/10790268.2018.1483593","article-title":"Surgical management of chordoma: A systematic review","volume":"43","author":"Denaro","year":"2018","journal-title":"J. Spinal Cord Med."},{"key":"ref_6","first-page":"174","article-title":"Chordoma: Immunohistochemical analysis of brachyury","volume":"28","author":"Sun","year":"2016","journal-title":"Turk. Neurosurg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ajcp\/72.5.765","article-title":"Chordoma: A Clinicopathologic Study of Metastasis","volume":"72","author":"Chambers","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/02841869209089717","article-title":"Chordoma-Natural History, Treatment and Prognosis the Florence Radiotherapy Department Experience (1956\u20131990) and a Critical Review of the Literature","volume":"31","author":"Magrini","year":"1992","journal-title":"Acta Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<878::AID-CNCR15>3.0.CO;2-7","article-title":"The surgical management of sacrococcygeal chordoma","volume":"85","author":"Yonemoto","year":"1999","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jocn.2015.05.036","article-title":"Metastatic saccrococcygeal chordoma","volume":"23","author":"Hassanabad","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"ref_11","first-page":"381","article-title":"Isolated liver metastasis from sacral chordoma. Case report and review of the literature","volume":"8","author":"Tavernaraki","year":"2003","journal-title":"J. Balk. Union Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1245\/s10434-017-6268-6","article-title":"Analysis of the Infiltrative Features of Chordoma: The Relationship between Micro-Skip Metastasis and Postoperative Outcomes","volume":"25","author":"Akiyama","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11604-012-0086-3","article-title":"Imaging characteristics of metastatic chordoma","volume":"30","author":"Kishimoto","year":"2012","journal-title":"Jpn. J. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1245\/s10434-009-0740-x","article-title":"Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers","volume":"17","author":"Stacchiotti","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-0142(19930801)72:3<714::AID-CNCR2820720314>3.0.CO;2-1","article-title":"Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases","volume":"72","author":"Fleming","year":"1993","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000096283","article-title":"Effectiveness of Cetuximab\/Gefitinib in the Therapy of a Sacral Chordoma","volume":"29","author":"Hof","year":"2006","journal-title":"Oncol. Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"565945","DOI":"10.3389\/fonc.2020.565945","article-title":"Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3171\/2011.5.JNS11185","article-title":"Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target","volume":"115","author":"Hsu","year":"2011","journal-title":"J. Neurosurg."},{"key":"ref_19","first-page":"e3772","article-title":"The Current Understanding of MicroRNA\u2019s Therapeutic, Diagnostic, and Prognostic Role in Chordomas: A Review of the Literature","volume":"10","author":"Choi","year":"2018","journal-title":"Cureus"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11060-013-1211-6","article-title":"MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas","volume":"115","author":"Bayrak","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41419-018-0738-z","article-title":"miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nec.2019.11.004","article-title":"New Prospects for Molecular Targets for Chordomas","volume":"31","author":"Ozair","year":"2020","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_23","first-page":"623","article-title":"Expression of PDGFR-\u03b1, EGFR and c-MET in spinal chor-doma: A series of 52 patients","volume":"34","author":"Gaab","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/path.4729","article-title":"EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen","volume":"239","author":"Scheipl","year":"2016","journal-title":"J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3171\/2011.12.JNS111123","article-title":"Establishment and characterization of a primary human chordoma xenograft model","volume":"116","author":"Siu","year":"2012","journal-title":"J. Neurosurg."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Siu, I.-M., Ruzevick, J., Zhao, Q., Connis, N., Jiao, Y., Bettegowda, C., Xia, X., Burger, P.C., Hann, C.L., and Gallia, G.L. (2013). Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078895"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1158\/1535-7163.MCT-17-0324","article-title":"Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury","volume":"17","author":"Magnaghi","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/cmdc.201900428","article-title":"Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for Chordoma","volume":"14","author":"Asquith","year":"2019","journal-title":"ChemMedChem"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1038\/s41598-020-70026-w","article-title":"Synergistic drug combinations and machine learning for drug repurposing in chordoma","volume":"10","author":"Anderson","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/7\/367\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:41:12Z","timestamp":1760139672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/7\/367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["curroncol29070367"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29070367","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}